Association between cannabis use and brain structure and function: an observational and Mendelian randomisation study.
Ishrat S. et al, (2024), BMJ Ment Health, 27
Association of Metabolic Syndrome With Neuroimaging and Cognitive Outcomes in the UK Biobank.
Qureshi D. et al, (2024), Diabetes Care, 47, 1415 - 1423
Feasibility of multiorgan risk prediction with routinely collected diagnostics: a prospective cohort study in the UK Biobank.
McCracken C. et al, (2024), BMJ Evid Based Med
Longitudinal alcohol-related brain changes in older adults: The Sydney Memory and Ageing Study.
Mewton L. et al, (2024), Addict Biol, 29
NHS Health Check attendance is associated with reduced multiorgan disease risk: a matched cohort study in the UK Biobank.
McCracken C. et al, (2024), BMC Med, 22
Binge-pattern alcohol consumption and genetic risk as determinants of alcohol-related liver disease.
Ding C. et al, (2023), Nat Commun, 14
Development and validation of a dementia risk score in the UK Biobank and Whitehall II cohorts.
Anatürk M. et al, (2023), BMJ Ment Health, 26
Association of gout with brain reserve and vulnerability to neurodegenerative disease.
Topiwala A. et al, (2023), Nat Commun, 14
Cardiometabolic health across menopausal years is linked to white matter hyperintensities up to a decade later.
Schindler LS. et al, (2023), Front Glob Womens Health, 4
Alcohol consumption and telomere length: Mendelian randomization clarifies alcohol's effects.
Topiwala A. et al, (2022), Mol Psychiatry, 27, 4001 - 4008
Alcohol consumption and MRI markers of brain structure and function: Cohort study of 25,378 UK Biobank participants.
Topiwala A. et al, (2022), Neuroimage Clin, 35
Subjective Cognitive Complaints Given in Questionnaire: Relationship With Brain Structure, Cognitive Performance and Self-Reported Depressive Symptoms in a 25-Year Retrospective Cohort Study.
Topiwala A. et al, (2021), Am J Geriatr Psychiatry, 29, 217 - 226
Development and Validation of a Novel Dementia Risk Score in the UK Biobank Cohort
Anaturk M. et al, (2021)
Association of trajectories of depressive symptoms with vascular risk, cognitive function and adverse brain outcomes: The Whitehall II MRI sub-study.
Demnitz N. et al, (2020), J Psychiatr Res, 131, 85 - 93